A
$ Value
$0
Shares
20,380
Price
$0
Filed
Jul 2
Insider
Name
Theagene Jean-Manasse
Title
—
CIK
0001969857
Roles
Director
Transaction Details
Transaction Date
2025-06-30
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
20,380
Footnotes
The stock options, granted on June 30, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
Filing Info
Theagene Jean-Manasse's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | MAIA | A | $0 |
| 2025-12-31 | MAIA | A | $0 |
| 2025-10-02 | MAIA | A | $0 |
| 2025-06-30 | MAIA | A | $0 |
Other Insiders at MAIA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CHAOUKI STEVEN M | — | — | 2026-03-31 |
| Smith Stan | — | — | 2026-03-31 |
|
Gryaznov Sergei
Chief Scientific Officer
|
— | — | 2026-04-10 |
| Guerrero Ramiro | — | — | 2026-03-31 |
|
Vitoc Vlad
Chief Executive Officer
|
— | — | 2026-04-10 |
| Louie Ngar Yee | — | — | 2026-03-31 |
| Luput Cristian | — | — | 2026-03-31 |
| Theagene Jean-Manasse | — | — | 2026-03-31 |
|
Himmelreich Jeffrey C
Head of Finance
|
— | — | 2026-04-10 |